Antiplatelet therapy: Clopidogrel-PPI interaction, an ongoing controversy.
Publication
, Journal Article
Gurbel, PA; Tantry, US
Published in: Nat Rev Cardiol
January 2011
Duke Scholars
Published In
Nat Rev Cardiol
DOI
EISSN
1759-5010
Publication Date
January 2011
Volume
8
Issue
1
Start / End Page
7 / 8
Location
England
Related Subject Headings
- Risk Assessment
- Proton Pump Inhibitors
- Practice Guidelines as Topic
- Platelet Aggregation Inhibitors
- Humans
- Evidence-Based Medicine
- Drug Interactions
- Clinical Trials as Topic
- Cardiovascular System & Hematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Gurbel, P. A., & Tantry, U. S. (2011). Antiplatelet therapy: Clopidogrel-PPI interaction, an ongoing controversy. Nat Rev Cardiol, 8(1), 7–8. https://doi.org/10.1038/nrcardio.2010.185
Gurbel, Paul A., and Udaya S. Tantry. “Antiplatelet therapy: Clopidogrel-PPI interaction, an ongoing controversy.” Nat Rev Cardiol 8, no. 1 (January 2011): 7–8. https://doi.org/10.1038/nrcardio.2010.185.
Gurbel PA, Tantry US. Antiplatelet therapy: Clopidogrel-PPI interaction, an ongoing controversy. Nat Rev Cardiol. 2011 Jan;8(1):7–8.
Gurbel, Paul A., and Udaya S. Tantry. “Antiplatelet therapy: Clopidogrel-PPI interaction, an ongoing controversy.” Nat Rev Cardiol, vol. 8, no. 1, Jan. 2011, pp. 7–8. Pubmed, doi:10.1038/nrcardio.2010.185.
Gurbel PA, Tantry US. Antiplatelet therapy: Clopidogrel-PPI interaction, an ongoing controversy. Nat Rev Cardiol. 2011 Jan;8(1):7–8.
Published In
Nat Rev Cardiol
DOI
EISSN
1759-5010
Publication Date
January 2011
Volume
8
Issue
1
Start / End Page
7 / 8
Location
England
Related Subject Headings
- Risk Assessment
- Proton Pump Inhibitors
- Practice Guidelines as Topic
- Platelet Aggregation Inhibitors
- Humans
- Evidence-Based Medicine
- Drug Interactions
- Clinical Trials as Topic
- Cardiovascular System & Hematology
- 1102 Cardiorespiratory Medicine and Haematology